Edition:
United Kingdom

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

2.84USD
14 Dec 2018
Change (% chg)

$-0.07 (-2.41%)
Prev Close
$2.91
Open
$2.88
Day's High
$3.06
Day's Low
$2.81
Volume
408,221
Avg. Vol
325,226
52-wk High
$5.24
52-wk Low
$1.91

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.00 -0.132
Jun '18 0.00 -0.124
Mar '18 0.15 -0.150
FY 2017 Dec '17 1.60 -0.130
Sep '17 1.60 -0.125
Jun '17 1.60 -0.131
Mar '17 1.60 -0.150
FY 2016 Dec '16 1.60 -0.113
Sep '16 1.60 -0.111
Jun '16 1.70 -1.006
Mar '16 1.97 -0.092
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 4 0.20 0.80 0.00 1.32
Quarter Ending Mar-19 3 1.63 4.90 0.00 --
Year Ending Dec-18 4 0.26 0.90 0.00 5.45
Year Ending Dec-19 3 1.07 3.20 0.00 6.40
Earnings (per share)
Quarter Ending Dec-18 4 -0.11 -0.08 -0.14 -0.16
Quarter Ending Mar-19 4 -0.09 -0.08 -0.09 --
Year Ending Dec-18 4 -0.51 -0.49 -0.55 -0.60
Year Ending Dec-19 4 -0.32 -0.26 -0.36 -0.66
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta 1.54 1.08 0.91
Price to Sales (TTM) 139.32 49.58 6.22
Price to Book (MRQ) -- 10.17 5.20
Price to Tangible Book (MRQ) 12.72 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions 54.51 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -5.89 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago -14.29 47.89 6.50
Sales - 5 Yr. Growth Rate 59.39 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.01 75.90 23.09
EPS (TTM) vs TTM 1 Yr. Ago 61.51 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -13.77 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 7.83 3.44 3.10
LT Debt to Equity (MRQ) 0.00 18.69 11.49
Total Debt to Equity (MRQ) 0.00 31.36 16.03
Interest Coverage (TTM) -- -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -762.28 -- --
EBITD - 5 Yr. Avg -3,432.75 -110.03 13.16
Operating Margin (TTM) -767.01 -185.03 6.07
Operating Margin - 5 Yr. Avg. -3,450.43 -126.47 8.47
Pre-Tax Margin (TTM) -789.28 -175.80 7.02
Pre-Tax Margin - 5 Yr. Avg. -3,320.66 -132.63 8.71
Net Profit Margin (TTM) -789.28 -182.53 3.12
Net Profit Margin - 5 Yr. Avg. -3,320.66 -137.03 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 177,472 7,648,872 873,051,409
Net Income/Employee (TTM) -1,400,750 653,324 103,483,755
Receivable Turnover (TTM) 216.58 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.05 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.58 6.47 11.45
Return on Assets - 5 Yr. Avg. -101.96 5.54 12.50
Return on Investment (TTM) -45.27 9.01 14.96
Return on Investment - 5 Yr. Avg. -120.26 6.87 16.23
Return on Equity (TTM) -- 10.15 16.52
Return on Equity - 5 Yr. Avg. -220.88 8.40 17.37
  1 Year 3 Year 5 Year
Sales % 58.38 104.69 59.39
EPS (TTM) % -38.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ZIOPHARM Oncology Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 1.46 -2.04 47 98
13 Week 1.62 -3.33 53 94
26 Week 0.48 -7.16 54 98
52 Week 11.57 -5.44 59 68
YTD 17.20 2.92 57 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 51.24%
# of Holders: 175
Total Shares Held: 72,954,145
3 Mo. Net Change: 15,274,120
# New Positions: 16
# Closed Positions: 16
# Increased Positions: 60
# Reduced Positions: 61
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.